Phase 4 Crohn's Disease and Colitis Trial, Recruiting NCT07550673 Sponsor: Xijing Hospital of Digestive Diseases Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 4 Crohn's Disease and Colitis Trial, Recruiting

NCT07550673
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with acute severe ulcerative colitis (a serious form of inflammatory bowel disease affecting the large intestine)
  • People who are 18 years of age or older
  • People of any gender

Who may not be able to join:

  • People who have a known allergy, intolerance, or medical reason preventing them from taking either of the study medications (upadacitinib or infliximab)
  • People who need urgent surgery to remove their colon, have Crohn's disease, have a confirmed gut infection, have unstable blood pressure or circulation, have a significant cytomegalovirus (a type of viral) infection, or currently have cancer
  • People who have serious ongoing conditions affecting major organs such as the heart, lungs, liver, kidneys, or blood
  • People who are pregnant or currently breastfeeding
  • People who are not willing to take part in a clinical study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 86-029-84771535

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Xijing Hospital of Digestive Diseases
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical response by day 7

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov